These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22968580)

  • 1. Greater risk of parkinsonism associated with non-N370S GBA1 mutations.
    Barrett MJ; Giraldo P; Capablo JL; Alfonso P; Irun P; Garcia-Rodriguez B; Pocovi M; Pastores GM
    J Inherit Metab Dis; 2013 May; 36(3):575-80. PubMed ID: 22968580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
    Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
    Blauwendraat C; Tayebi N; Woo EG; Lopez G; Fierro L; Toffoli M; Limbachiya N; Hughes D; Pitz V; Patel D; Vitale D; Koretsky MJ; Hernandez D; Real R; Alcalay RN; Nalls MA; Morris HR; Schapira AHV; Balwani M; Sidransky E
    Mov Disord; 2023 May; 38(5):899-903. PubMed ID: 36869417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
    Ghatti S; Yoon E; Lopez G; Ehrlich D; Horovitz SG
    J Neurol; 2022 Oct; 269(10):5347-5355. PubMed ID: 35604467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of olfactory function in individuals with Gaucher disease and
    Lopez GJ; Lichtenberg J; Tayebi N; Ryan E; Lecker AL; Sidransky E
    Front Neurol; 2022; 13():1039214. PubMed ID: 36330429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of Parkinson's disease in type 1 Gaucher disease.
    Bultron G; Kacena K; Pearson D; Boxer M; Yang R; Sathe S; Pastores G; Mistry PK
    J Inherit Metab Dis; 2010 Apr; 33(2):167-73. PubMed ID: 20177787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
    Surface M; Balwani M; Waters C; Haimovich A; Gan-Or Z; Marder KS; Hsieh T; Song L; Padmanabhan S; Hsieh F; Merchant KM; Alcalay RN
    Mov Disord; 2022 Feb; 37(2):416-421. PubMed ID: 34741486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.
    Zhang CK; Stein PB; Liu J; Wang Z; Yang R; Cho JH; Gregersen PK; Aerts JM; Zhao H; Pastores GM; Mistry PK
    Am J Hematol; 2012 Apr; 87(4):377-83. PubMed ID: 22388998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
    Taddei TH; Kacena KA; Yang M; Yang R; Malhotra A; Boxer M; Aleck KA; Rennert G; Pastores GM; Mistry PK
    Am J Hematol; 2009 Apr; 84(4):208-14. PubMed ID: 19260119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Transcranial Sonography and [
    Eisenberg DP; Lopez G; Gregory MD; Berman KF; Sidransky E
    Mov Disord; 2022 Mar; 37(3):629-634. PubMed ID: 34762337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies of GBA1-associated parkinsonism: progress and challenges.
    Lopez G; Monestime G; Sidransky E
    Neurodegener Dis Manag; 2016; 6(1):1-4. PubMed ID: 26782311
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
    Burke DG; Rahim AA; Waddington SN; Karlsson S; Enquist I; Bhatia K; Mehta A; Vellodi A; Heales S
    J Inherit Metab Dis; 2013 Sep; 36(5):869-72. PubMed ID: 23151684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
    DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E
    Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis.
    Saffie Awad P; Teixeira-Dos-Santos D; Santos-Lobato BL; Camargos S; Cornejo-Olivas M; de Mello Rieder CR; Mata IF; Chaná-Cuevas P; Klein C; Schumacher Schuh AF
    Mov Disord; 2024 Jan; 39(1):6-16. PubMed ID: 37921246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.
    Thirumal Kumar D; Eldous HG; Mahgoub ZA; George Priya Doss C; Zayed H
    Metab Brain Dis; 2018 Dec; 33(6):1835-1847. PubMed ID: 29978341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase and its relevance to Parkinson disease.
    Do J; McKinney C; Sharma P; Sidransky E
    Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
    García-Sanz P; Orgaz L; Bueno-Gil G; Espadas I; Rodríguez-Traver E; Kulisevsky J; Gutierrez A; Dávila JC; González-Polo RA; Fuentes JM; Mir P; Vicario C; Moratalla R
    Mov Disord; 2017 Oct; 32(10):1409-1422. PubMed ID: 28779532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.